Experts will discuss developing the opioid overdose rescue drug naloxone hydrochloride for over-the-counter (OTC) sales during a 2-day meeting in December that’s aimed at finding new ways to make the medication more widely available.
“This potentially life-saving treatment is a critical tool for individuals, families, first responders, and communities to help reduce opioid overdose deaths,” FDA Commissioner Scott Gottlieb, MD, said in a statement. Gottlieb noted that the number of overdose deaths from prescription and illicit opioids has doubled in recent years, from 21 089 in 2010 to 42 249 in 2016.
Voelker R. Will Naloxone Become Available OTC?. JAMA. 2018;320(19):1970. doi:10.1001/jama.2018.17836
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: